Essential Elixir: Harnessing Antioxidant Power to Combat Staphyloxanthin-Producing Staphylococcus Aureus

The general observation indicates that EOs can be utilized as therapeutic agents in the treatment of S. aureus infections especially SPSA-causing strains on the basis of their antioxidant property, they suppress the formation of STX, stimulate immune response and promote clinical outcome. The insights can be useful in considering the application of EO as alternative treatment of multidrug-resistant strains, as such approach is natural and may be rather effective. Nevertheless, additional in vivo and clinical studies are required to confirm the effectiveness, safety, and the potential of EOs as supplementary treatment to conventional antibiotics. Also, in future studies, emphasis must be made on the identification of particular constituents and action mechanisms of synergistic interactions between the various constituents in EOs that are involved in their antimicrobial activity against SPSA isolates.

Ahmad, A., Khan, A., Akhtar, F., Yousuf, S., Xess, I., Khan, L., and Manzoor, N., 2011. Fungicidal activity of thymol and carvacrol by disrupting ergosterol biosynthesis and membrane integrity against Candida. Eur. J. Clin. Microbiol. Infect. Dis. 30, 41–50. https://doi.org/10.1007/s10096-010-1050-8 De Carvalho, S., De Almeida, J., De Freitas, L., Guimaraes, A., Do Nascimento, N., Dos Santos, A., Campos, G., Messick, J., Timenetsky, J., and Marques, L. M., 2019. Genomic profile of Brazilian methicillin-resistant Staphylococcus aureus resembles clones dispersed worldwide. Journal of Medical Microbiology, 68, 693–702. https://doi.org/ 10.1099/jmm.0.000956 Edris, A.E., 2007. Pharmaceutical and therapeutic potentials of essential oils and their individual volatile constituents: a review. Phytotherapy Research, 4, 308-323. https://doi.org/10.1002/ptr.2072 Escajadillo, T., and Nizet, V., 2018. Pharmacological targeting of pore-forming toxins as adjunctive therapy for invasive bacterial infection. Toxins 10, 542. https://doi.org/ 10.3390/toxins10120542 Hasani-Ranjbar, S., Nayebi, N., Larijani, B., and Abdollahi, M., 2009. A systematic review of the efficacy and safety of herbal medicines used in the treatment of obesity. World J Gastroenterol, 15(25), 3073-3085. https://doi.org/10.3748/wjg.15.3073 Jorgensen, J. H., Pfaller, M. A., Carroll, K. C., Funke, G., Landry, M. L., Richter, S.S., Warnock, D. W., 2015. Manual of Clinical Microbiology, 11th ed., American Society of Microbiology, Washington, DC. Kulisic, T., Radonic, A., Katalinic, V., Milos, M., 2004. Use of different methods for testing antioxidative activity of oregano essential oil. Food Chemistry, 85 (4), 633-640. https://doi.org/10.1016/j.foodchem.2003.07.024 Kuroda, M., Nagasaki, S., Ito, R., and Ohta, T., 2007.  Sesquiterpene farnesol inhibits recycling of the C55 lipid carrier of the murein monomer precursor contributing to increased susceptibility to β-lactams in methicillin-resistant Staphylococcus aureus. Journal of Antimicrobial Chemotherapy, 59, 425–432. https://doi.org/10.1093/jac/dkl519